HKAM
BLUE

Horizon Kinetics Asset Management’s bluebird bio BLUE Stock Holding History

Horizon Kinetics Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,747
Closed -$18.1K – 351
2024
Q3 		$18.1K Sell
1,747
-76
-4% -$1.26K ﹤0.01% 343
2024
Q2 		$35.9K Hold
1,823
– – ﹤0.01% 321
2024
Q1 		$46.7K Hold
1,823
– – ﹤0.01% 317
2023
Q4 		$50.3K Sell
1,823
-77
-4% -$4.7K ﹤0.01% 317
2023
Q3 		$116K Hold
1,900
– – ﹤0.01% 306
2023
Q2 		$125K Hold
1,900
– – ﹤0.01% 310
2023
Q1 		$121K Buy
+1,900
New +$217K ﹤0.01% 310

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Horizon Kinetics Asset Management's BLUE Position: Q4 2024 in Review

Horizon Kinetics Asset Management sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 1,747 shares — an estimated $18.1K sold.

Horizon Kinetics Asset Management first reported a position in BLUE in Q1 2023 and held it in 7 quarters. The position peaked at $125K in Q2 2023. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Horizon Kinetics Asset Management reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Horizon Kinetics Asset Management sold 1,747 bluebird bio shares in Q4 2024, an estimated $18.1K.
  • Horizon Kinetics Asset Management first reported a position in bluebird bio in Q1 2023 and held it in 7 quarters.
  • Horizon Kinetics Asset Management's bluebird bio position peaked at $125K in Q2 2023.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Horizon Kinetics Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.